ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
143 hedge funds and large institutions have $571M invested in Array Biopharma Inc in 2013 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 42 increasing their positions, 50 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
16% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 50
83% less call options, than puts
Call options by funds: $771K | Put options by funds: $4.48M
Holders
143
Holding in Top 10
6
Calls
$771K
Puts
$4.48M
Top Buyers
| 1 | +$40M | |
| 2 | +$12.6M | |
| 3 | +$3.96M | |
| 4 |
DM
Deerfield Management
New York
|
+$3.26M |
| 5 |
PA
Pinnacle Associates
New York
|
+$3.1M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$9.06M | |
| 3 | -$8.39M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$3.56M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$3.44M |